AMG
XBI icon

Asset Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Asset Management Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Sell
20,433
-204
-1% -$25.5K 0.42% 62
2025
Q4 		$2.52M Sell
20,637
-3,020
-13% -$346K 0.41% 61
2025
Q3 		$2.37M Buy
23,657
+5
+0% +$450 0.39% 62
2025
Q2 		$1.96M Buy
23,652
+2
+0% +$160 0.34% 65
2025
Q1 		$1.92M Buy
23,650
+2
+0% +$179 0.35% 66
2024
Q4 		$2.13M Sell
23,648
-498
-2% -$48.2K 0.38% 64
2024
Q3 		$2.39M Buy
24,146
+3
+0% +$295 0.42% 62
2024
Q2 		$2.24M Buy
24,143
+27
+0.1% +$2.42K 0.42% 63
2024
Q1 		$2.29M Buy
24,116
+8
+0% +$742 0.43% 61
2023
Q4 		$2.15M Buy
24,108
+3
+0% +$223 0.43% 61
2023
Q3 		$1.76M Hold
24,105
– – 0.39% 63
2023
Q2 		$2.01M Buy
24,105
+1
+0% +$84 0.43% 62
2023
Q1 		$1.84M Hold
24,104
– – 0.41% 66
2022
Q4 		$2M Hold
24,104
– – 0.47% 64
2022
Q3 		$1.91M Sell
24,104
-73
-0.3% -$6.15K 0.48% 61
2022
Q2 		$1.8M Hold
24,177
– – 0.43% 64
2022
Q1 		$2.17M Hold
24,177
– – 0.45% 61
2021
Q4 		$2.71M Sell
24,177
-202
-0.8% -$24.4K 0.53% 55
2021
Q3 		$3.06M Sell
24,379
-392
-2% -$50.5K 0.63% 47
2021
Q2 		$3.35M Sell
24,771
-1,286
-5% -$169K 0.69% 43
2021
Q1 		$3.54M Sell
26,057
-201
-0.8% -$30.1K 0.77% 42
2020
Q4 		$3.7M Buy
26,258
+31
+0.1% +$3.97K 0.9% 39
2020
Q3 		$2.92M Sell
26,227
-288
-1% -$32.3K 0.85% 39
2020
Q2 		$2.97M Buy
26,515
+4
+0% +$394 0.94% 38
2020
Q1 		$2.05M Hold
26,511
– – 0.77% 45
2019
Q4 		$2.52M Sell
26,511
-150
-0.6% -$13K 0.76% 43
2019
Q3 		$2.03M Buy
26,661
+1
+0% +$83 0.7% 44
2019
Q2 		$2.34M Sell
26,660
-136
-0.5% -$11.6K 0.83% 39
2019
Q1 		$2.43M Hold
26,796
– – 0.88% 38
2018
Q4 		$1.92M Buy
26,796
+4
+0% +$322 0.79% 42
2018
Q3 		$2.57M Buy
26,792
+20
+0.1% +$1.94K 0.87% 40
2018
Q2 		$2.55M Sell
26,772
-297
-1% -$27.3K 0.89% 37
2018
Q1 		$2.38M Buy
27,069
+17
+0.1% +$1.55K 0.85% 39
2017
Q4 		$2.3M Sell
27,052
-1,286
-5% -$108K 0.83% 40
2017
Q3 		$2.45M Buy
28,338
+13
+0% +$1.04K 0.92% 38
2017
Q2 		$2.19M Buy
28,325
+38
+0.1% +$2.69K 0.85% 41
2017
Q1 		$1.96M Sell
28,287
-326
-1% -$21.9K 0.78% 42
2016
Q4 		$1.69M Buy
28,613
+8
+0% +$494 0.7% 44
2016
Q3 		$1.9M Buy
28,605
+13
+0% +$804 0.79% 41
2016
Q2 		$1.55M Buy
28,592
+25
+0.1% +$1.37K 0.67% 45
2016
Q1 		$1.48M Buy
28,567
+31
+0.1% +$1.61K 0.65% 46
2015
Q4 		$2M Buy
28,536
+59
+0.2% +$4.02K 0.91% 37
2015
Q3 		$1.77M Buy
28,477
+10
+0% +$788 0.83% 37
2015
Q2 		$2.39M Buy
28,467
+51
+0.2% +$3.97K 1.08% 33
2015
Q1 		$2.14M Buy
28,416
+498
+2% +$34.8K 0.99% 32
2014
Q4 		$1.74M Buy
27,918
+69
+0.2% +$3.93K 0.87% 32
2014
Q3 		$1.45M Buy
27,849
+198
+0.7% +$10.1K 0.77% 35
2014
Q2 		$1.42M Buy
27,651
+57
+0.2% +$2.57K 0.77% 35
2014
Q1 		$1.31M Buy
27,594
+9
+0% +$461 0.75% 35
2013
Q4 		$1.2M Buy
27,585
+18
+0.1% +$745 0.73% 34
2013
Q3 		$1.19M Buy
27,567
+12
+0% +$486 0.77% 31
2013
Q2 		$958K Buy
+27,555
New +$968K 0.66% 34

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Asset Management Group's XBI Position: Q1 2026 in Review

Asset Management Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.99% in Q1 2026, selling an estimated $25.5K and leaving 20,433 shares worth $2.61M. The position accounts for 0.42% of the portfolio, ranked #62.

Asset Management Group first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.7M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Asset Management Group held 20,433 shares of State Street SPDR S&P Biotech ETF worth $2.61M as of Q1 2026.
  • Asset Management Group sold 204 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $25.5K.
  • State Street SPDR S&P Biotech ETF made up 0.42% of Asset Management Group's portfolio in Q1 2026, its #62 holding.
  • Asset Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
  • Asset Management Group's State Street SPDR S&P Biotech ETF position peaked at $3.7M in Q4 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Asset Management Group's 13F filing for Q1 2026, filed 15 May 2026.